Your browser doesn't support javascript.
loading
Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy.
Sallach, Jessica; Di Pasquale, Giovanni; Larcher, Fernando; Niehoff, Nadine; Rübsam, Matthias; Huber, Anke; Chiorini, Jay; Almarza, David; Eming, Sabine A; Ulus, Hikmet; Nishimura, Stephen; Hacker, Ulrich T; Hallek, Michael; Niessen, Carien M; Büning, Hildegard.
Afiliação
  • Sallach J; 1] Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany [2] Department I for Internal Medicine, University Hospital Cologne, Cologne, Germany.
  • Di Pasquale G; Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
  • Larcher F; Centro de Investigacion Energetica Medioambiental y Tecnologica (CIEMAT) Madrid, Center for Biomedical Research on Rare Diseases (CIBERER-U714) and Department of Bioengineering. Universidad Carlos III de Madrid (UC3M), Madrid, Spain.
  • Niehoff N; 1] Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany [2] Department of Dermatology, University Hospital of Cologne, Cologne, Germany.
  • Rübsam M; 1] Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany [2] Department of Dermatology, University Hospital of Cologne, Cologne, Germany.
  • Huber A; 1] Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany [2] Department I for Internal Medicine, University Hospital Cologne, Cologne, Germany.
  • Chiorini J; Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.
  • Almarza D; 1] Centro de Investigacion Energetica Medioambiental y Tecnologica (CIEMAT) Madrid, Center for Biomedical Research on Rare Diseases (CIBERER-U714) and Department of Bioengineering. Universidad Carlos III de Madrid (UC3M), Madrid, Spain [2] Current address: Molecular Immunology, UCL Institute of Chil
  • Eming SA; 1] Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany [2] Department of Dermatology, University Hospital of Cologne, Cologne, Germany [3] Cologne Excellence Center on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
  • Ulus H; Children's Medical Surgery, Cologne, Germany.
  • Nishimura S; Department of Pathology & Laboratory Medicine, Anatomic Pathology, UCSF, San Francisco, CA, USA.
  • Hacker UT; University Cancer Center Leipzig (UCCL), Leipzig, Germany.
  • Hallek M; 1] Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany [2] Department I for Internal Medicine, University Hospital Cologne, Cologne, Germany.
  • Niessen CM; 1] Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany [2] Department of Dermatology, University Hospital of Cologne, Cologne, Germany [3] Cologne Excellence Center on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
  • Büning H; 1] Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany [2] Department I for Internal Medicine, University Hospital Cologne, Cologne, Germany.
Mol Ther ; 22(5): 929-39, 2014 May.
Article em En | MEDLINE | ID: mdl-24468915

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Anormalidades da Pele / Terapia Genética / Engenharia Genética Limite: Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Anormalidades da Pele / Terapia Genética / Engenharia Genética Limite: Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Alemanha